(Q38012465)

English

Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy

scientific article published on June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 August 2017

Circulating nucleosomes and biomarkers of immunogenic cell death as predictive and prognostic markers in cancer patients undergoing cytotoxic therapy (English)

1 reference

Europe PubMed Central

27 August 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Oliver J Stoetzer

1

1 reference

Europe PubMed Central

27 August 2017

Christin Wittwer

2

1 reference

Europe PubMed Central

27 August 2017

Julia Lehner

3

1 reference

Europe PubMed Central

27 August 2017

Yvonne N Fahmueller

4

1 reference

Europe PubMed Central

27 August 2017

Nikolaus Kohles

5

1 reference

Europe PubMed Central

27 August 2017

Debora M I Fersching

6

1 reference

Europe PubMed Central

27 August 2017

Gloria Leszinski

7

1 reference

Europe PubMed Central

27 August 2017

Juliane Roessner

8

1 reference

Europe PubMed Central

27 August 2017

Stefan Holdenrieder

9

1 reference

Europe PubMed Central

27 August 2017

language of work or name

0 references

publication date

1 June 2012

1 reference

Europe PubMed Central

27 August 2017

Expert Opinion on Biological Therapy

1 reference

Europe PubMed Central

27 August 2017

12 Suppl 1

1 reference

Europe PubMed Central

27 August 2017

S217-24

1 reference

Europe PubMed Central

27 August 2017

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Tumor response assessments with diffusion and perfusion MRI.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Strategies for discovering novel cancer biomarkers through utilization of emerging technologies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Clinical relevance of circulating nucleosomes in cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Nucleosomes indicate the in vitro radiosensitivity of irradiated bronchoepithelial and lung cancer cells.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Plasma nucleosome levels might predict response to therapy in patients with advanced non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Circulating nucleosomes predict the response to chemotherapy in patients with advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Nucleosomes in pancreatic cancer patients during radiochemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Early prediction of therapy response in patients with acute myeloid leukemia by nucleosomal DNA fragments

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Elevated nucleosome levels in systemic inflammation and sepsis

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Nucleosomes in serum of patients with early cerebral stroke.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Nucleosomal DNA fragments in autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Nucleosomes in the pathogenesis of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Molecular characteristics of immunogenic cancer cell death.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Immunological aspects of cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

HMGB1 and RAGE in inflammation and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

HMGB1 loves company

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Serum cathepsin K and cystatin C concentration in patients with advanced non-small-cell lung cancer during chemotherapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

High-mobility group box 1 and cancer

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Multiple levels of regulation determine the role of the receptor for AGE (RAGE) as common soil in inflammation, immune responses and diabetes mellitus and its complications

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Tumor-cell death, autophagy, and immunity

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

HMGB1 release and redox regulates autophagy and apoptosis in cancer cells

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Serum high mobility group box protein 1 as a clinical marker for non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation Therapy

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Relevance of circulating nucleosomes and oncological biomarkers for predicting response to transarterial chemoembolization therapy in liver cancer patients

1 reference

https://api.crossref.org/works/10.1517%2F14712598.2012.689280

21 January 2018

Identifiers

10.1517/14712598.2012.689280

1 reference

Europe PubMed Central

27 August 2017

1 reference

Europe PubMed Central

27 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38012465&oldid=1737275756"